Inhibitors of ribonucleotide reductase subunit 2 and uses thereof

Details for Australian Patent Application No. 2006230436 (hide)

Owner Calando Pharmaceuticals, Inc.

Inventors Heidel, Jeremy D.; Roosi, John J.; Davis, Mark E.

Agent Shelston IP

Pub. Number AU-B-2006230436

PCT Pub. Number WO2006/105361

Priority 60/667,362 31.03.05 US; 60/695,931 30.06.05 US; 60/742,100 02.12.05 US

Filing date 31 March 2006

Wipo publication date 5 October 2006

Acceptance publication date 24 November 2011

International Classifications

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/105361 Priority application(s): WO2006/105361

24 November 2011 Application Accepted

  Published as AU-B-2006230436

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006230447-Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors

2006230434-Methods for stimulating hair growth by administering BMPs